Drugs / Isolagen TherapyTM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00620737 | Feb → Dec 2008 | — | Castle Creek Biosciences, LLC. | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Isolagen TherapyTM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00620737 ↗ |
| Known as | Autologous Human Fibroblasts | “Autologous Human Fibroblasts (Isolagen TherapyTM)” NCT00620737 ↗ |
| Modality | Cell therapy | “Autologous Human Fibroblasts (Isolagen TherapyTM)” NCT00620737 ↗ |